Iris Miedema – Research output — Amsterdam UMC research portal

Research activity per year

7 Article
4 Meeting Abstract
1 Review article

4 results

Filter

2021

Tumor uptake of the anti-LAG-3 tracer [89Zr]Zr-BI 754111 in HNSCC and NSCLC patients progressing on previous anti-PD-1 treatment
Miedema, IHC., Huisman, MC., Zwezerijnen, GJC., Thiele, A., Grempler, R., Pitarch, A., Vugts, DJ., de Gruijl, TD. & Menke, C. W., 2021, In: European journal of nuclear medicine. 48, SUPPL 1, p. S301
Research output: Contribution to journal › Meeting Abstract › Academic
2020

Zr-89-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.
Verhoeff, S., van de Donk, P. P., Aarntzen, E. H. J. G., Miedema, I. H. C., Oosting, S., Voortman, J., Brouwers, A. H., Slingerland, M., Heskamp, S. & Van Herpen, C. M. L., 20 May 2020, In: Journal of clinical oncology. 38, 15
Research output: Contribution to journal › Meeting Abstract › Academic
2019

First-in-human imaging of nanoparticle entrapped docetaxel (CPC634) in patients with advanced solid tumors using 89Zr-Df-CPC634 PET/CT.
Miedema, IHC., Zwezerijnen, GJC., Oprea - Lager, D., Verheul, HMW., Vugts, DJ., Huisman, MC., Mathijssen, R. H. J., Rijcken, C., Hu, Q., van Dongen, G. & Menke, C. W., 20 May 2019, In: Journal of clinical oncology. 37, 15, p. 3093-3093
Research output: Contribution to journal › Meeting Abstract › Academic

Open Access
Tumor uptake and biodistribution of 89Zirconium-labeled ipilimumab in patients with metastatic melanoma during ipilimumab treatment
Miedema, IHC., Zwezerijnen, GJC., Oprea - Lager, D., Verheul, HMW., Vugts, DJ., Huisman, MC., Hoekstra, OS., de Gruijl, TD., Verheul, HMW., Menke, C. W. & van den Eertwegh, AJM., Jul 2019, In: Clinical Cancer Research. 1136.
Research output: Contribution to journal › Meeting Abstract › Academic

Open Access